Brief: Sabby Management LLC Reports 8.02 Pct Passive Stake In Actinium Pharmaceuticals
April 18 (Reuters) - Actinium Pharmaceuticals Inc ATNM.A :
* SABBY MANAGEMENT LLC REPORTS 8.02 PERCENT PASSIVE STAKE IN
ACTINIUM PHARMACEUTICALS INC AS OF APRIL 18 - SEC FILING
Source text : (http://bit.ly/2Vf1RG4)
Further company coverage: ATNM.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Actinium Pharmaceuticals
See all newsBrief: Actinium Pharmaceuticals - Receives Two Canadian Patent Allowances For Actimab-A And Iomab-Act Programs
Brief: ctinium’s Atnm-400 Shows Strong Efficacy in TNBC, Beats Therapy Resistance at SABCS
Brief: Actinium Pharmaceuticals Says ATNM-400 Shows Superior Efficacy To Xtandi In Prostate Cancer
Brief: Actinium Pharmaceuticals Announces ATNM-400 A Novel Non-PSMA Targeting First In Class Prostate Cancer Radiotherapy Leveraging Actinium-225
Brief: Actinium Pharmaceuticals Announces Supply Agreement With Eckert & Ziegler For AC-225 Radioisotope To Support Comprehensive Development Activities